Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Pictured: Clifford Hudis
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, December 5, 2012

New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: Carol Brown
Video
By Memorial Sloan Kettering  |  Wednesday, November 28, 2012

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

In the News
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 16, 2012

Memorial Sloan Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Pictured: Jatin Shah
Video
By Memorial Sloan Kettering  |  Monday, November 12, 2012

Dr. Shah, Chief of the Head and Neck Service, discusses how Memorial Sloan Kettering’s world-renowned head and neck surgeons partner with patients to select the most appropriate treatment plan.

Pictured: Martin Weiser
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, November 8, 2012

Memorial Sloan Kettering’s colorectal cancer team has developed online prediction tools that assess disease risk following surgery, enabling patients and physicians to make better treatment decisions.

Pictured: Ping Chi
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Pictured: James Huang
Video
By Memorial Sloan Kettering  |  Wednesday, October 31, 2012

Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.

Pictured: Nadeem Abu-Rustum
Video
By Memorial Sloan Kettering  |  Monday, October 22, 2012

Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.

Pictured: Robin Roberts
In the News
By Media Staff  |  Thursday, October 11, 2012

Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.

In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, September 17, 2012

When new cancer drugs are shown to be largely ineffective, exceptional cases of good outcome may pave the way for new treatments that could benefit a smaller group of patients.

Center News

Stay Informed

Get the latest information about cancer care and research every month.